Home > BIGG > Search result

    Results: 2

    COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

    England. National Institute for Health and Care Excellence.
    The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID 19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resource...
    Gastrointestinal Diseases/therapy, Gastrointestinal Diseases/diagnosis, Liver Diseases/therapy, Liver Diseases/diagnosis, Immunity, Active/immunology, Immunity, Active/drug effects, Betacoronavirus, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control
    Fulltext

    Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado

    Martín-Llahí, M; Albillos, A; Bañares, R; Berzigotti, A; García-Criado, M. Á; Genescà, J; Hernández-Gea, V; Llop-Herrera, E; Masnou-Ridaura, H; Mateo, J; Navascués, C. A; Puente, Á; Romero-Gutiérrez, M; Simón-Talero, M; Téllez, L; Turon, F; Villanueva, C; Zarrabeitia, R; García-Pagán, J. C.
    Gastroenterol. hepatol. (Ed. impr.); 40 (8), 2017
    Las enfermedades vasculares hepáticas, a pesar de su relativamente baja prevalencia, representan un problema de salud importante en el campo de las enfermedades hepáticas. Una característica común a muchas de estas enfermedades es que pueden causar hipertensión portal, con la elevada morbimortalidad...
    Vascular Diseases/diagnosis, Budd-Chiari Syndrome/therapy, Thrombosis/therapy, Hepatic Veno-Occlusive Disease/therapy, Telangiectasia, Hereditary Hemorrhagic/therapy, Arteriovenous Fistula/therapy, Vascular Diseases/therapy, Liver Diseases/diagnosis, Liver Diseases/therapy
    Fulltext